Dr. Jen wrote on:
17 alpha hydroxyprogesterone 17OP aluminum cerebral palsy congenital heart defect congenital heart disease disability eating disorder fine motor skill fine motor skills flu going home hands health insurance hypotonia influenza KV Pharmaceuticals losing a baby Makena March of Dimes medicaid NEC NICU omega-3 OT perseverance pertussis Play-Doh preeclampsia preemie progesterone RediWhip RSV running safety stress Synagis Tae Kwon Do tests Thanksgiving turkey vaccine vaccines whooping cough writing-
Recent Posts
- Preventing prematurity: the importance of getting screened for Chlamydia
- Ther-Rx skips ACOG: the people have spoken. But can we do more?
- What does replacing the word retarded with intellectual disability accomplish?
- Cigna’s automatic denials: asshattery in action
- ACOG’s double standard on Makena: denouncing Ther-Rx but taking advertising dollars
Blogroll
Archives
Tag Archives: KV Pharmaceuticals
Rep. Henry Waxman demands answers from Ther-Rx about Makena
Rep. Henry Waxman, Rep. Frank Pallone, Jr., and Rep. Diana DeGette sent a letter on March 24th to Gregory Divis, the CEO of Ther-Rx, regarding the pricing of Makena (see below). Of note, the honorable Mr. Waxman, Mr. Pallone, Jr, and Ms. … Continue reading
The March of Dimes really responds to Ther-Rx and price of Makena, well, sort of…
Today (March 23rd) Dr. Jennifer Howse of the March of Dimes (MOD) finally responded to the egregious price gouging/extortion that is Makena (17 Alpha-hydroxyprogesterone caproate, or 17OP, newly packaged as an orphan drug). As we all know, this travesty was … Continue reading
Posted in Uncategorized
Tagged 17 alpha hydroxyprogesterone, 17OP, KV Pharmaceuticals, Makena, March of Dimes
9 Comments
Makena hits the market and it’s a show down at the OK corral
March 21rst. Today is the day that Makena, KV pharmaceuticals “brand” of 17 alpha-hydroxyprogesterone caproate (17OP) hits the market. It’s not really a brand name drug. It has been used for a variety of indications in pregnancy since the 1950′s … Continue reading
The impact of Makena on Medicaid: KV Pharamceuticals’ extortion of tax payers
Makena, KV Pharmaceuticals version of 17 alpha-hydroxyprogesterone caproate or 17OP (for prevention of preterm labor) is priced at $1500 a shot (up from $10 a shot prior to the meddling of the FDA). Considering most women who are eligible will … Continue reading
Posted in Uncategorized
Tagged 17 hydroxyprogesterone, 17OP, FDA, KV Pharmaceuticals, Makena, March of Dimes
7 Comments
March of Dimes response to Makena pricing reveals they are woefully out of touch
Preemie message boards are all fired up by KV Pharmaceutical’s pricing of 17 Alpha-hydroxy progesterone caproate (17P, a hormone than can help prevent premature delivery for some women who have previously delivered prematurely). Once KV was awarded the patent, the … Continue reading